Abstract
Objective: To describe the effects of percutaneously implanted valve-in-valve in the tricuspid position for patients with pre-existing transvalvular device leads. Methods: In this case series, we describe implantation of the Melody valve and SAPIEN XT valve within dysfunctional bioprosthetic tricuspid valves in three patients with transvalvular device leads. Results: In all cases, the valve was successfully deployed and device lead function remained unchanged. In 1/3 cases with 6-month follow-up, device lead parameters remain unchanged and transcatheter valve-in-valve function remains satisfactory. Conclusions: Transcatheter tricuspid valve-in-valve is feasible in patients with pre-existing transvalvular devices leads. Further study is required to determine the long-term clinical implications of this treatment approach.
| Original language | English (US) |
|---|---|
| Journal | Catheterization and Cardiovascular Interventions |
| DOIs | |
| State | Accepted/In press - 2015 |
Fingerprint
Keywords
- Percutaneous valve therapy
- Structural heart disease intervention
- Transcatheter valve implantation
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine
- Radiology Nuclear Medicine and imaging
Cite this
Transcatheter tricuspid valve-in-valve in patents with transvalvular device leads. / Eleid, Mackram; Asirvatham, Samuel J; Cabalka, Allison K.; Hagler, Donald J.; Noseworthy, Peter; Taggart, Nathaniel W.; Rihal, Charanjit.
In: Catheterization and Cardiovascular Interventions, 2015.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Transcatheter tricuspid valve-in-valve in patents with transvalvular device leads
AU - Eleid, Mackram
AU - Asirvatham, Samuel J
AU - Cabalka, Allison K.
AU - Hagler, Donald J.
AU - Noseworthy, Peter
AU - Taggart, Nathaniel W.
AU - Rihal, Charanjit
PY - 2015
Y1 - 2015
N2 - Objective: To describe the effects of percutaneously implanted valve-in-valve in the tricuspid position for patients with pre-existing transvalvular device leads. Methods: In this case series, we describe implantation of the Melody valve and SAPIEN XT valve within dysfunctional bioprosthetic tricuspid valves in three patients with transvalvular device leads. Results: In all cases, the valve was successfully deployed and device lead function remained unchanged. In 1/3 cases with 6-month follow-up, device lead parameters remain unchanged and transcatheter valve-in-valve function remains satisfactory. Conclusions: Transcatheter tricuspid valve-in-valve is feasible in patients with pre-existing transvalvular devices leads. Further study is required to determine the long-term clinical implications of this treatment approach.
AB - Objective: To describe the effects of percutaneously implanted valve-in-valve in the tricuspid position for patients with pre-existing transvalvular device leads. Methods: In this case series, we describe implantation of the Melody valve and SAPIEN XT valve within dysfunctional bioprosthetic tricuspid valves in three patients with transvalvular device leads. Results: In all cases, the valve was successfully deployed and device lead function remained unchanged. In 1/3 cases with 6-month follow-up, device lead parameters remain unchanged and transcatheter valve-in-valve function remains satisfactory. Conclusions: Transcatheter tricuspid valve-in-valve is feasible in patients with pre-existing transvalvular devices leads. Further study is required to determine the long-term clinical implications of this treatment approach.
KW - Percutaneous valve therapy
KW - Structural heart disease intervention
KW - Transcatheter valve implantation
UR - http://www.scopus.com/inward/record.url?scp=84928957897&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84928957897&partnerID=8YFLogxK
U2 - 10.1002/ccd.25990
DO - 10.1002/ccd.25990
M3 - Article
C2 - 25946058
AN - SCOPUS:84928957897
JO - Catheterization and Cardiovascular Interventions
JF - Catheterization and Cardiovascular Interventions
SN - 1522-1946
ER -